Outcomes Research & AMR:
Defining the Value of Healthcare Interventions in Antimicrobial Resistance
Resilient health systems are at the core of solid economies and have long-lasting and far-reaching societal benefits. CIDRAP-ASP has developed a three-paper series to explore the emerging role of outcomes research in public health. In this first paper, we define outcomes research and explore how the concept has evolved over time and can be applied to research. We will focus primarily on its impact on antimicrobial resistance (AMR). Advocacy for the implementation of prevention measures or the development and use of tools to control the spread of drug-resistant infections across communities has not raised sufficient funds. Outcomes research can help shift the focus on the benefits of action, as the multidimensional interplay between the various factors that make health interventions sustainable.